Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 17;19(16):10203.
doi: 10.3390/ijerph191610203.

Prevalence and Factors Associated with Metabolic Syndrome in Patients at a Psychosocial Care Center: A Cross-Sectional Study

Dandara Almeida Reis da Silva  1 , Ludmila Santana de Almeida  1 , Livia Lugarinho Correa  2 , Rodrigo Fernandes Weyll Pimentel  1   3   4   5 , Antonio Marcos Tosoli Gomes  6 , Ana Gabriela Travassos  1   7 , Adriana Mattos Viana  1 , Monique Magnavita Borba da Fonseca Cerqueira  1   3 , Marcio Costa de Souza  1 , Anderson Reis de Sousa  8 , Paulo José Bastos Barbosa  1 , Julita Maria Freitas Coelho  5   9 , Lucelia Batista Neves Cunha Magalhães  10 , Argemiro D'Oliveira Júnior  3 , Jorge Lopes Cavalcante Neto  1 , Charles Souza Santos  11 , Luiz Carlos Moraes França  6 , Juliana de Lima Brandão  6 , Livia Fajin de Mello Dos Santos  6 , Helena Ferraz Gomes  6 , Ellen Marcia Peres  6 , Thais Regis Aranha Rossi  1 , Kairo Silvestre Meneses Damasceno  1   3 , Millena Conceição das Mercês  10 , Sandra Lúcia Fernandes  12 , Eline de Almeida Soriano  12 , Isolda Prado de Negreiros Nogueira Maduro  12 , Tatiana Santos Brandão  4 , Amanda Cardoso Menezes  5   13 , Amália Ivine Costa Santana  4 , Magno Conceição das Merces  1   3   5   10
Affiliations

Prevalence and Factors Associated with Metabolic Syndrome in Patients at a Psychosocial Care Center: A Cross-Sectional Study

Dandara Almeida Reis da Silva et al. Int J Environ Res Public Health. .

Abstract

Background: Metabolic syndrome (MS) is associated with greater risk of morbimortality and it has high prevalence in people with mental illness.

Objective: Estimate the prevalence of Metabolic Syndrome (MS) and its associated factors in the patients of a Psychosocial Care Center (CAPS in Brazilian Portuguese) in the city of Salvador, state of Bahia, Brazil.

Method: Cross-sectional study set at CAPS in the city of Salvador-Bahia between August 2019 and February 2020. MS was evaluated according to the National Cholesterol Education Program's Adult Treatment Panel III. In addition to descriptive statistics, gross and adjusted prevalence ratios were described.

Results: MS was found in 100 (35.2%) individuals, 116 (40.9%) were obese and 165 (58.1%) had increased waist circumference. Polypharmacy was identified in 63 (22.3%) patients and 243 (85.9%) used antipsychotics. Under gross evaluation, women (PR = 1.88; 95%CI: 1.35-2.63) and those who used antidepressants (PR = 1.41; 95%CI: 1.05-1.88) showed an association with MS. After logistic regression, depression (PR = 1.86; 95%CI: 1.38-2.51), acanthosis (PR = 1.50; 95%CI: 1.18-1.90), use of antipsychotics (PR = 1.88; 95%CI: 1.13-2.75), and hypertriglyceridemic waist (PR = 3.33; 95%CI: 2.48-4.46) were associated with MS.

Conclusion: The prevalence of MS signals multimorbidity among individuals with mental disorders and suggests a need for clinical screening.

Keywords: mental disorders; metabolic syndrome; multimorbidity; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mottillo S., Bs C., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., Rinfret S., Schiffrin E.L., Eisenberg M.J. The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis. J. Am. Coll. Cardiol. 2010;56:1113–1132. doi: 10.1016/j.jacc.2010.05.034. - DOI - PubMed
    1. Stern M.P., Williams K., González-Villalpando C., Hunt K.J., Haffner S.M. Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Diabetes Care. 2004;27:2676–2681. doi: 10.2337/diacare.27.11.2676. - DOI - PubMed
    1. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., Montori V.M. Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies. J. Am. Coll. Cardiol. 2007;49:403–414. doi: 10.1016/j.jacc.2006.09.032. - DOI - PubMed
    1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C., Jr., et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. - DOI - PubMed
    1. Moore J.X., Chaudhary N., Akinyemiju T. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev. Chronic Dis. 2017;14:E24. doi: 10.5888/pcd14.160287. - DOI - PMC - PubMed

Substances